Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil

Fedeli, Ligia G; Vidigal, Pedro G; Leite, Claudia Mendes; Castilhos, Cristina D; Pimentel, Robércia Anjos; Maniero, Viviane C; Mill, Jose Geraldo; Lotufo, Paulo A; Pereira, Alexandre C; Bensenor, Isabela M

doi:10.1590/S0034-8910.2013047003807

home Sumário navigate_before Anterior Atual Seguinte navigate_next

home Sumário

Articles • Rev. Saúde Pública 47 (Suppl 2) • June 2013 • https://doi.org/10.1590/S0034-8910.2013047003807 linkcopy

Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil

Authorship SCIMAGO INSTITUTIONS RANKINGS

Abstracts

The ELSA (Estudo Longitudinal de Saúde do Adulto - Brazilian Longitudinal Study for Adult Health) is a multicenter cohort study which aims at the identification of risk factors associated with type 2 diabetes and cardiovascular diseases in the Brazilian population. The paper describes the strategies for the collection, processing, transportation, and quality control of blood and urine tests in the ELSA. The study decided to centralize the tests at one single laboratory. The processing of the samples was performed at the local laboratories, reducing the weight of the material to be transported, and diminishing the costs of transportation to the central laboratory at the Universidade de São Paulo Hospital. The study included tests for the evaluation of diabetes, insulin resistance, dyslipidemia, electrolyte abnormalities, thyroid hormones, uric acid, hepatic enzyme abnormalities, inflammation, and total blood cell count. In addition, leukocyte DNA, urine, plasma and serum samples were stored. The central laboratory performed approximately 375,000 tests.

Clinical Laboratory Information Systems; Diagnostic Techniques and Procedures; Logistics; Hematologic Tests; Urinalysis; Multicenter Studies as Topic, methods; Cohort Studies

vertical_align_top show_chart

more_horiz close
- image
- translate
- link
- article
- vertical_align_top
- file_download
- show_chart
- image
- translate
- link
- article

location_on

Faculdade de Saúde Pública da Universidade de São Paulo Avenida Dr. Arnaldo, 715, 01246-904 São Paulo SP Brazil, Tel./Fax: +55 11 3061-7985 - São Paulo - SP - Brazil
E-mail: revsp@usp.br

rss_feed Acompanhe os números deste periódico no seu leitor de RSS

[TFN01t04] IFCC: International Federation of Clinical Chemistry and Laboratory Medicin

1 ^stcollection after 12-hour fasting	03 tubes (8.5 mL) with clot activator gel; 03 EDTA tubes (4 mL); 01 fluoride/oxalate tube (2 mL); 02 tubes (4,5 mL) containing citrate as anticoagulant; and 01 tube (4 mL) with heparin.
Fasting tests	Blood glucose, glycated hemoglobin (HbA1c), creatinine, sodium, potassium, uric acid, aspartate transaminase (AST), alanine transaminase (ALT), gamma-glutamyl transferase (γ GT), total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, TSH, insulin and free T4 only for the individuals who presented altered TSH, ultrasensitive C-reactive protein, and Serology for Chagas Disease.
Post-collection procedure	Non-diabetics: ingestion of a glucose solution to be submitted to the oral glucose tolerance test; Diabetics: food load composed of four toasts, four cheese cubes.
2 ^ndcollection 120 min after the beginning of the ingestion of the glucose solution for the non-diabetics and of the food load for the diabetics	Second collection two hours after the end of the ingestion of the glucose solution or food load in which the following tubes were collected through venipuncture with vacuum scalp: 01 tube (8,5 mL) with clot activator gel; 01 tube (4mL) with heparin; 01 fluoride/oxalate tube (2 mL).
Post-collection procedure	Snack

Test	Objective	Method	Equipment	Reference value

Blood glucose	Determination of diabetes	Hexokinase method (enzymatic) ²⁵	ADVIA 1200 Siemens®	Fasting: 70 to 99 mg/dL 120 minutes after ingestion of glucose solution:
				< 140 mg/dL: normal tolerance to glucose 140 to 199 mg/dL: glucose intolerance
				≥ 200 mg/dL: diabetes
Total cholesterol	Lipid metabolism	Cholesterol oxidase method (enzymatic colorimetric) ¹	ADVIA 1200 Siemens®	Desirable: < 200 mg/dL Borderline: 200-239 mg/dL High: > 240 mg/dL
HDL-cholesterol	Lipid metabolism	Homogeneous, colorimetric, without precipitation ³⁴	ADVIA 1200 Siemens®	Desirable values: Non-diabetics:> 40 mg/dL diabetics: > 45 mg/dL
Triglycerides	Lipid metabolism	Glycerol-phosphate peroxidase method according to Trinder (enzymatic colorimetric) ¹⁷	ADVIA 1200 Siemens®	< 150 mg/dl
LDL-cholesterol Used when triglycerides ≤ 400 mg/dl.	Lipid metabolism	Friedewald Equation		Desirable for:
				High risk patients: < 100 mg/dL
				Medium risk patients: <130 mg/dL
				Low risk patients: < 160 mg/dL
LDL-cholesterol Used when triglycerides > 400 mg/dl	Lipid metabolism	Homogeneous, enzymatic, colorimetric method without precipitation ²⁶	ADVIA 1200 Siemens®	Desirable for:
				High risk individuals: < 100 mg/dL Medium risk individuals:
				<130 mg/dL Low risk individuals:
				< 160 mg/dL
Creatinine	Renal function	Jaffe’s Method ²²	ADVIA 1200 Siemens®	Serum: 0.4 to 1.3 mg/dL 12-hour urine: not established
Uric acid	Purine metabolism marker	Uricase method (enzymatic colorimetric) ¹⁶	ADVIA 1200 Siemens®	Men: 3.5 to 7.2 mg/dL
				Women: 2.6 to 6.0 mg/dL
Aspartate aminotransferase	Identifier for hepatic steatosis	Modified IFCC (enzymatic) ²⁹	ADVIA 1200 Siemens®	Men: 10 to 35 U/L
				Women: 10 to 31 U/L
Alanine	Identificador para esteatose hepática	Modified IFCC (enzymatic) ²⁸	ADVIA 1200 Siemens®	Men: 9 to 43 U/L
				Women: 9 to 36 U/L
γ-glutamyl-transferase	Identifier for hepatic and alcoholic steatosis	Szasz Persijn (kinetic colorimetric) ³⁰	ADVIA 1200 Siemens®	Men: 2 a 30 U/L
				Women: 1 a 24 U/L
Ultrasensitive C-Reactive Protein	Inflammatory marker	Immunochemistry through nephelometry ¹⁴	nephelometer BN II Siemens®	For cardiovascular risk assessment:
				Low risk: < 1.0mg/L
				Medium risk: 1.0 a 3.0 mg/L
				High risk: > 3.0 mg/L
Glycated hemoglobin	Determination of diabetes	High-pressure chromatography (HPLC) ²⁰	Variant Bio Rad®	< 5.7% Normal tolerance to glucose
TSH	Etiological investigation	Immunoenzymatic assay ^23,35	Centaur Siemmens®	0.55 – 4.78 mcUI/mL
Free T4	Etiological investigation	Immunoenzymatic assay ^26,35	Centaur Siemmens®	0.89 to 1.76 ng/dL
Insulin	Carbohydrate metabolism	Immunoenzymatic assay ^23,35	Centaur Siemmens®	Fasting:3.0 - 25.0 mUI/L After ingestion of glucose solution:
				Not established
Urine Na	Food intake	Potentiometry with ion-selective electrode	ADVIA 1200 Siemens®	Not established
Urine K	Food intake	Potentiometry with ion-selective electrode	ADVIA 1200 Siemens®	Not established
Urine calcium	Food intake	Potentiometry with ion-selective electrode) ¹⁸	ADVIA 1200 Siemens®	Not established
Microalbuminuria	Endothelial function	Immunochemistry through nephelometry	nephelometer BN II Siemens®	Normal: < 20 μg/m in
				Microalbuminuria: 20 to 200 μg/min
				Macroalbuminuria: > 200 μg/min
Serology for Chagas Disease	Differential diagnosis in cardiomyopathies	ELISA with solid-phase microplates – reagent WIENER (CHAGASTEST) ¹⁵	Microplate incubator/reader	Not reactive